Jane Street
RCKT icon

Jane Street’s Rocket Pharmaceuticals RCKT Stock Holding History

Jane Street’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,600
Closed -$45.1K – 12857
2026
Q1 		$45.1K Buy
+12,600
New +$50.1K ﹤0.01% 11009
2025
Q4 		– Sell
-45,700
Closed -$149K – 12147
2025
Q3 		$149K Buy
45,700
+5,400
+13% +$17K ﹤0.01% 9884
2025
Q2 		$98.7K Buy
+40,300
New +$204K ﹤0.01% 8953
2024
Q4 		– Sell
-10,200
Closed -$188K – 10359
2024
Q3 		$188K Sell
10,200
-3,300
-24% -$67.6K ﹤0.01% 8687
2024
Q2 		$291K Buy
13,500
+1,700
+14% +$39K ﹤0.01% 7852
2024
Q1 		$318K Sell
11,800
-209,200
-95% -$5.94M ﹤0.01% 7467
2023
Q4 		$6.62M Sell
221,000
-29,300
-12% -$647K ﹤0.01% 2464
2023
Q3 		$5.13M Buy
+250,300
New +$4.55M ﹤0.01% 2571
2022
Q4 		– Sell
-19,300
Closed -$308K – 9960
2022
Q3 		$308K Buy
19,300
+500
+3% +$7.8K ﹤0.01% 7545
2022
Q2 		$259K Buy
+18,800
New +$224K ﹤0.01% 7828
2021
Q2 		– Sell
-7,600
Closed -$337K – 10297
2021
Q1 		$337K Sell
7,600
-5,600
-42% -$307K ﹤0.01% 7512
2020
Q4 		$724K Buy
+13,200
New +$481K ﹤0.01% 5169

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jane Street's RCKT Position: Q2 2026 in Review

Jane Street sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 623,354 shares — an estimated $2.23M sold.

Jane Street first reported a position in RCKT in Q3 2020 and held it in 21 quarters. The position peaked at $3.28M in Q3 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Jane Street reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 623,354 Rocket Pharmaceuticals shares in Q2 2026, an estimated $2.23M.
  • Jane Street first reported a position in Rocket Pharmaceuticals in Q3 2020 and held it in 21 quarters.
  • Jane Street's Rocket Pharmaceuticals position peaked at $3.28M in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.